28 July 2026 : Original article
Prevalence and Risk Factors of Hepatic Steatosis in Kidney Transplant Recipients
Monika Górska
ABCDEF 1*, Filip Wróbel ABCDEF 2, Marta Rząsa ABCDEF 2, Ilona Kurnatowska ACDEF 1
DOI: 10.12659/AOT.952251
Ann Transplant 2026; 31:e952251
Table 3 Univariable logistic regression analyses of variables potentially associated with the presence of de novo hepatic steatosis in kidney transplant recipients.
| OR (95% CI) | P value | |
|---|---|---|
| Pre-KTx BMI | 1.18 (1.05–1.32) | 0.005* |
| Post-KTx BMI | 1.22 (1.09–1.36) | <0.001* |
| Age at analysis | 1.00 (0.97–1.04) | 0.925 |
| Total cholesterol | 1.01 (1.00–1.02) | 0.014* |
| Triglycerides | 1.01 (1.00–1.02) | 0.005* |
| High-density lipoprotein | 1.00 (0.97–1.02) | 0.871 |
| Low-density lipoprotein | 1.02 (1.00–1.03) | 0.013* |
| Sex (male) | 1.78 (0.80–3.96) | 0.154 |
| Ischemic heart disease | 3.21 (1.28–8.01) | 0.013* |
| Hyperlipidemia | 2.68 (1.12–6.43) | 0.027* |
| Hyperuricemia | 3.06 (1.37–6.85) | 0.007* |
| Hypertension arterialis | 4.61 (0.55–38.25) | 0.157 |
| Diabetes mellitus | 1.11 (0.48–2.54) | 0.807 |
| ADPKD | 1.01 (0.39–2.57) | 0.976 |
| ACE-I/ARB | 1.02 (0.46–2.25) | 0.960 |
| Serum creatinine | 1.30 (0.57–2.99) | 0.533 |
| eGFR (Cockroft-Gault) | 1.01 (0.99–1.02) | 0.363 |
| BMI change | 1.13 (0.98–1.29) | 0.088 |
| Values are presented as odds ratios (OR) with 95% confidence intervals (CI) and values. * Indicates P values less than 0.05. KTx – kidney transplantation; ADPKD – autosomal polycystic kidney disease; ACE-I – angiotensin-converting enzyme inhibitors; ARB – angiotensin II receptor blockers. | ||